Search research articles
Contact Us
Filters
Showing results (771-780 of 809) with videos related to
Page
of 81
Sort By:
European Journal of Heart Failure
|
November 7, 2019
Plasma proteomic approach in patients with heart failure: insights into pathogenesis of disease progression and potential novel treatment targets
Thong H Cao, Donald J L Jones, Adriaan A Voors, et al.
European Journal of Heart Failure
|
December 19, 2017
Proteomic diversity of high-density lipoprotein explains its association with clinical outcome in patients with heart failure
Johanna Elisabeth Emmens, Donald J L Jones, Thong H Cao, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
January 6, 2019
Prognostic significance of changes in heart rate following uptitration of beta-blockers in patients with sub-optimally treated heart failure with reduced ejection fraction in sinus rhythm versus atrial fibrillation
Ify R Mordi, Bernadet T Santema, Mariëlle Kloosterman, et al.
Lancet (London, England)
|
August 23, 2011
The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial
John G F Cleland, John R Teerlink, Roxy Senior, et al.
BMJ Open
|
May 28, 2025
Clinical effectiveness and cost-effectiveness of the rehabilitation enablement in chronic heart failure facilitated self-care rehabilitation intervention for people with heart failure with preserved ejection fraction and their caregivers: rationale and protocol for a multicentre randomised controlled trial - REACH-HFpEF trial
Rod S Taylor, Emma Burrell, Claire O'Hare, et al.
European Journal of Heart Failure
|
January 11, 2020
Genetic risk and atrial fibrillation in patients with heart failure
Mariëlle Kloosterman, Bernadet T Santema, Carolina Roselli, et al.
Journal of Internal Medicine
|
May 7, 2020
Tumour biomarkers: association with heart failure outcomes
C Shi, H H van der Wal, H H W Silljé, et al.
European Journal of Heart Failure
|
December 19, 2020
Is acute heart failure a distinctive disorder? An analysis from BIOSTAT-CHF
Beth A Davison, Stefanie Senger, Iziah E Sama, et al.
Journal of Virology
|
October 13, 2025
Optimization of VE607 to generate analogs with improved neutralization activities against SARS-CoV-2 variants
Shilei Ding, Derek Yang, Irfan Ullah, et al.
Trials
|
April 15, 2022
Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS)
Seonaidh Cotton, Graham Devereux, Hassan Abbas, et al.
Page
of 81
Search research articles
Search
Showing results (771-780 of 809) with videos related to
Sort By:
Page
of 81
European Journal of Heart Failure
|
November 7, 2019
Plasma proteomic approach in patients with heart failure: insights into pathogenesis of disease progression and potential novel treatment targets
Thong H Cao, Donald J L Jones, Adriaan A Voors, et al.
European Journal of Heart Failure
|
December 19, 2017
Proteomic diversity of high-density lipoprotein explains its association with clinical outcome in patients with heart failure
Johanna Elisabeth Emmens, Donald J L Jones, Thong H Cao, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
January 6, 2019
Prognostic significance of changes in heart rate following uptitration of beta-blockers in patients with sub-optimally treated heart failure with reduced ejection fraction in sinus rhythm versus atrial fibrillation
Ify R Mordi, Bernadet T Santema, Mariëlle Kloosterman, et al.
Lancet (London, England)
|
August 23, 2011
The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial
John G F Cleland, John R Teerlink, Roxy Senior, et al.
BMJ Open
|
May 28, 2025
Clinical effectiveness and cost-effectiveness of the rehabilitation enablement in chronic heart failure facilitated self-care rehabilitation intervention for people with heart failure with preserved ejection fraction and their caregivers: rationale and protocol for a multicentre randomised controlled trial - REACH-HFpEF trial
Rod S Taylor, Emma Burrell, Claire O'Hare, et al.
European Journal of Heart Failure
|
January 11, 2020
Genetic risk and atrial fibrillation in patients with heart failure
Mariëlle Kloosterman, Bernadet T Santema, Carolina Roselli, et al.
Journal of Internal Medicine
|
May 7, 2020
Tumour biomarkers: association with heart failure outcomes
C Shi, H H van der Wal, H H W Silljé, et al.
European Journal of Heart Failure
|
December 19, 2020
Is acute heart failure a distinctive disorder? An analysis from BIOSTAT-CHF
Beth A Davison, Stefanie Senger, Iziah E Sama, et al.
Journal of Virology
|
October 13, 2025
Optimization of VE607 to generate analogs with improved neutralization activities against SARS-CoV-2 variants
Shilei Ding, Derek Yang, Irfan Ullah, et al.
Trials
|
April 15, 2022
Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS)
Seonaidh Cotton, Graham Devereux, Hassan Abbas, et al.
Page
of 81